Volume 20, Number 2—February 2014
CME ACTIVITY - Online Report
Peer Reviewed Report Available Online Only
Special Considerations for Prophylaxis for and Treatment of Anthrax in Pregnant and Postpartum Women
Medscape, LLC is pleased to provide online continuing medical education (CME) for this journal article, allowing clinicians the opportunity to earn CME credit.
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Medscape, LLC and Emerging Infectious Diseases. Medscape, LLC is accredited by the ACCME to provide continuing medical education for physicians.
Medscape, LLC designates this Journal-based CME activity for a maximum of 1 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
All other clinicians completing this activity will be issued a certificate of participation. To participate in this journal CME activity: (1) review the learning objectives and author disclosures; (2) study the education content; (3) take the post-test with a 70% minimum passing score and complete the evaluation at www.medscape.org/journal/eid; (4) view/print certificate.
Release date: January 15, 2014; Expiration date: January 15, 2015
Upon completion of this activity, participants will be able to:
• Describe the challenges in diagnosis and diagnostic testing of anthrax during pregnancy
• Distinguish the preferred prevention strategy for pregnant women exposed to Bacillus anthracis
• Assess other treatment courses for pregnant women exposed to anthrax
• Evaluate the treatment of active anthrax infection during pregnancy and lactation.
Shannon O’Connor, ELS, Technical Writer/Editor, Emerging Infectious Diseases. Disclosure: Shannon O’Connor has disclosed no relevant financial relationships.
Charles P. Vega, MD, Health Sciences Clinical Professor; Residency Director, Department of Family Medicine, University of California, Irvine. Disclosure: Charles P. Vega, MD, has disclosed no relevant financial relationships.
Disclosures: Dana Meaney-Delman, MD, MPH; Marianne E. Zotti, DrPH, MS; Andreea A. Creanga, MD, PhD; Lara K. Misegades, PhD; Etobssie Wako, MPH; Tracee Treadwell, RN, DVM, MPH; Nancy E. Messonnier, MD; and Denise Jamieson, MD, MPH, have disclosed no relevant financial relationships.
- Page created: January 17, 2014
- Page last updated: January 17, 2014
- Page last reviewed: January 17, 2014
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)